Ripac New Build – Latest news

Ripac-Labor GmbH, a fully owned subsidiary of Dopharma International B.V., specializes in veterinary services and the production of autogenous vaccines for livestock. These customized vaccines provide targeted protection against farm-specific pathogens, offering a crucial tool for disease prevention and control. The expansion of Ripac-Labor’s production capabilities further strengthens the Dopharma group’s position in the European veterinary market.

The company currently employs 48 academic specialists, experienced laboratory technicians, and other well-trained staff.

Dopharma is a family-owned pharmaceutical company dedicated to producing and supplying high-quality veterinary pharmaceuticals for livestock since 1969. With 95% of its veterinary pharmaceuticals manufactured in-house at its GMP-certified production facilities, Dopharma ensures strict quality control and continuous innovation. The company’s mission is to provide smart, science-driven solutions that support the health and productivity of livestock worldwide.

www.dopharma.com

For media inquiries which are not available on this site, please contact [email protected].